SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-14-066104
Filing Date
2014-09-12
Accepted
2014-09-12 16:01:30
Documents
5
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a14-20586_110q.htm 10-Q 820098
2 EX-31.1 a14-20586_1ex31d1.htm EX-31.1 12720
3 EX-31.2 a14-20586_1ex31d2.htm EX-31.2 12258
4 EX-32.1 a14-20586_1ex32d1.htm EX-32.1 7127
5 EX-32.2 a14-20586_1ex32d2.htm EX-32.2 7109
  Complete submission text file 0001104659-14-066104.txt   860301
Mailing Address 1 LANDMARK SQUARE, SUITE 1122 STAMFORD CT 06901
Business Address 1 LANDMARK SQUARE, SUITE 1122 STAMFORD CT 06901 203-658-4749
Loxo Oncology, Inc. (Filer) CIK: 0001581720 (see all company filings)

IRS No.: 462996673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36562 | Film No.: 141100877
SIC: 2834 Pharmaceutical Preparations